Recall of Losartan

HealthPharmacy
Last updated on
Avatar photo
By Bryan Tan Van Hong

Publicity Associate at YPC. Currently working in Esyms, an online pharmacy platform and Registered Pharmacist at a retail pharmacy. Oh, and not to forget, pun enthusiast.

On early March, the Ministry of Health Malaysia released a statement regarding the recall of 7 types of medication containing the active ingredient Losartan. This came about after some of these angiotension II receptor blocker (ARB) were found to contain unacceptable amount of nitrosamine, a substance which is possibly carcinogenic, or has the potential to cause cancer.

The seven types of medications recalled were Losagen 50, Losagen 100, Losartas 50mg Tablets, Losartas 100mg Tablets, Tozaar Plus LS 50/12.5mg Tablet, Tozaar 50mg Tablet and Tozaar Tablet 100mg.

Deputy Minister Dr Lee Boon Chye urged those who are in possession of the aforementioned medication to return it to the supplier in exchange for other approved medication. Stern actions will also be taken on suppliers who continue to sell these medications.

However, there is no need to panic, says Dr Lee. “Do not panic if you have consumed the medications, as there are no short-term effects.”

This is not the first time losartan has been recalled from the market. Last year, a similar incident occured where the company which supplied Lostad HCT 50/12.5 mg was asked to cease its operation.

Be sure to visit your local pharmacy or clinic for any enquiries. Do not stop taking any medications on your own accord.

 

Related

Remdesivir: Yay or Nay?

Last updated on
Since our last article on Remdesivir, much has been discovered about its potential clinical application via several high-profile clinical trials. On 15th October 2020, we first heard of less-than-promising results from the WHO SOLIDARITY trial that Remdesivir has “little to no effect on hospitalized COVID-19, as indicated by overall mortality, initiation of ventilation, and duration...

Starting from 1 January 2019, all applications for pharmacy licenses and permits will be associated with a newly imposed fee. The amendments are as follow: “I) Di bawah Peraturan 28 Peraturan-Peraturan Racun (Pindaan) 2018 iaitu :  28. (1) An Application for a licence under the Act shall be accompanied by the following fees:    …

Written by Tang Jia Wen, commitee member of MCPS 2.5   On 27 July 2019, the Malaysian Clinical Pharmacy Symposium (MCPS) 2.5 – A Cancer Therapy Counselling Workshop was held in International Medical University (IMU). It had successfully gathered pharmacists from different backgrounds and provided a conducive platform for them to exchange ideas and thoughts…

NDMA Found in Ranitidine

Last updated on

Written by Bryan Tan – Marketing and Communications Associate at YPC, currently a PRP at a retail pharmacy, and pun enthusiast   Recently, there has been news regarding the discovery of traces of N-Nitrosodimethylamin (NDMA) found in ranitidine medications. This was reported by the American-based Food and Drug Administration (FDA) as well as the Singaporean…

Thinking Outside the KOTAK

Last updated on

Written by Bryan Tan – Marketing and Communications Associate at YPC, currently a PRP at a retail pharmacy, and pun enthusiast   Established in 2016, the Oral Health Program – Kesihatan Oral Tanpa Asap Rokok (KOTAK) is a prominent initiative by the Ministry of Health Malaysia and the Ministry of Education Malaysia which aims to…

Since our last article on COVID-19, so much has changed-the number of reported cases, better understanding of the virus’ characteristics, and its rebranding to COVID-19. After a harrowing month into the new decade, there’s finally some good news in 2020! This article will cover the rationale behind rebranding, latest statistics, and the roles of pharmacists…

Others

  With new digital technologies growing increasingly involved in contemporary healthcare, an upcoming symposium aims to place the implications for patient welfare at the centre of the discussion. This October, the third edition of the Malaysian Innovative Healthcare Symposium 2018 (MIHS 2018) will bring together healthcare professionals to explore the potential of current and upcoming…

FIPYPG’s 20th Anniversary

Last updated on
The following piece is a compilation in conjunction with FIPYPG’s 20th Anniversary. Established in 2007, the Malaysian Pharmacists Society-Young Pharmacists Chapter (MPS-YPC) has been a prominent chapter under the umbrella of MPS. It was set up with the aim of bringing together young pharmacists, which currently form the largest cohort of the profession, to shape...
Image by cromaconceptovisual from Pixabay
In the last quarter of 2020, you have probably heard of the mutated UK variant of SARS-CoV2, B-117 that is much more infectious and responsible for two-thirds of the COVID-19 cases in the UK. It is reported that the new variant is about 30-50% more contagious than the original strain. One has to wonder, is...
[UPDATE] As of 8/12/2020 The Light at the End of the Tunnel On 8 December, the United Kingdom has been the very first nation to begin vaccinating its citizens. 90 year-old Margaret Keenan was the first Briton to receive the Pfizer/BioNTech vaccine. The UK has also placed an order for the Moderna vaccines for a...

WHO to look into drug pricing?

Last updated on

Our health ministry has urged the World Health Organisation (WHO) to look into drug pricing by major drug companies. This came about amidst the pressure on the ministry to utilise Compulsory Licensing (CL)* to gain access to generic versions of a Hepatitis C medication. “I hope the international community could look at how pharmaceutical companies…

Here is a reminder to the smoking ban at eateries which will be officially implemented in 3 days’ time. Like many other laws, it has garnered mixed reactions and divided opinions from the public. Since its announcement back in October, many were sceptical and doubtful on the substance of this. Was the law really going…